Synovial Sarcoma
What's New
Last Posted: Dec 26, 2024
- Histologic and immunologic factors associated with response to immune checkpoint inhibitors in advanced sarcoma.
Alex Q Lee, et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 0 - Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A?02-eligible patients.
Tianjiao Wang, et al. Molecular therapy. Methods & clinical development 2024 0 (2) 101265 - A bioinformatics analysis of the clinicopathological and prognostic significance of FAM64A mRNA expression in gynecological cancers.
Hua-Chuan Zheng, et al. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 2023 0 (1) 2216280 - Integrating Molecular Sequencing Into the Pathological Diagnosis of Clinically Suspected Non-Small Cell Lung Carcinomas.
Lo Ying-Chun, et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 0 (5) 100126 - Spindle Epithelial Tumor with Thymus-Like Differentiation (SETTLE): A Next-Generation Sequencing Study.
Stevens Todd M, et al. Head and neck pathology 2018 0 (2) 162-168 - Analysis of Multiple Drug Resistance Mechanism in Different Types of Soft Tissue Sarcomas: Assessment of the Expression of ABC-Transporters, MVP, YB-1, and Analysis of Their Correlation with Chemosensitivity of Cancer Cells.
Moiseeva Natalia I, et al. International journal of molecular sciences 2022 0 (6) - HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome.
Rosenbaum Evan, et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 8 - Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas.
van IJzendoorn David G P et al. PLoS computational biology 2019 15(2) e1006826 - Clinical Utility of In Situ Hybridization Assays in Head and Neck Neoplasms.
Luk Peter P et al. Head and neck pathology 2018 Nov - Preclinical Evaluation of Vemurafenib as Therapy for BRAF V600E Mutated Sarcomas.
Gouravan Sarina et al. International journal of molecular sciences 2018 Mar 19(4)
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: